Pharmacotherapy used for alcohol and cocaine use disorders in a CAPS-AD of Minas Gerais

• Autor(a) principal: Costa, Anna Carolina de Moura
• Data de Publicação: 2022
• Outros Autores: Freitas, Laura Maciel de, Tranin, Geny Carolina Gomes, Sales, Thais Lorenna Souza, Pestana, Ana Cristina Nogueira Rodrigues, Alpoim, Patrícia Nessralla, Sanches, Cristina, Chequer, Farah Maria Drumond
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Brazilian Journal of Pharmaceutical Sciences
• Texto Completo: https://www.revistas.usp.br/bjps/article/view/204093
• topic: Cocaine; Alcoholism; Substance-Related Disorders; Benzodiazepines; Disulfiram

Substance use disorder is one of the major social and public health problems in the world.The present study analyzed the pharmacoepidemiological profile of patients treated at thePsychosocial Treatment Center for Alcohol and Substance Use Disorders (CAPS-AD) fortreatment of alcohol use disorders (AUD), cocaine use disorders (CUD) and concomitant alcoholand cocaine use disorders (A-CUD) in the city of Betim-MG. The study used quantitativeand descriptive data and was based on the evaluation of medical records of patients attendedfrom January to December 2016. After analyzing 295 medical records, the majority of studyparticipants were male (83.7 %) with an average age of 46.26 for AUD, 28.88 for CUD and 34.29for A-CUD. The most prescribed drugs for AUD were diazepam (54.1 %), thiamine (37 %),complex B vitamins (29.5 %), and disulfiram (2.7 %); for CUD, diazepam (26.9 %) and haloperidol(23.1 %). It should be noticed that although contraindicated by the guidelines, chlorpromazine(42.3 %, 25.3 %, 20.3 %) was prescribed for CUD, AUD, and A-CUD respectively. Knowingthe pharmacoepidemiological profile of CAPS-AD patients is extremely important for makingdecisions regarding which medicines to make available to the population.